Financial figures

Overview of DSM's latest financial key figures

Key financials

Presented below are DSM's net salesbalance sheet, income statement and cash flow statement as at FY 2022*.

* From Q1 2021 onwards, in line with the established practice of many of DSM's consumer ingredients peers, we provide trading updates for Q1 and Q3 reporting sales, organic growth, Adjusted EBITDA and Adjusted EBITDA margins.

We report full financial details for half year and full year results and host calls for the media and analysts for both.

Net sales

in € million

YearQ1Q2Q3Q4Total
20231,889¹    
20222,008¹2,107¹2,182¹2,093¹8,390¹
20211,727¹1,790¹1,825¹1,928¹7,269¹
20202,045²2,020²1,961²2,080²8,106²
20192,021²2,008²2,035²1,934²7,998²
20182,4352,3592,2652,2089,267
20172,1592,1612,1362,1768,632
20161,9131,9941,9982,0157,920
20151,8861,7542,1021,9267,722
20142,2982,2882,3232,1759,181
20132,3762,4682,3972,3779,618
20122,2902,2682,3042,2699,131
20112,2342,2652,3222,2279,048
20101,9332,1202,0412,0828,176
20091,5781,6641,7251,7586,725
20082,3032,4062,3362,0349,079

¹ Figures reflect continuing operations which include DSM’s Health, Nutrition & Bioscience and Corporate Activities. In May 31, 2022 DSM announced the sale of DSM Protective Materials and DSM Engineering Materials. All of DSM’s Materials businesses were reclassified to discontinued operations.

²  Figures reflect the reclassification of the DSM’s Resins & Functional Materials businesses to discontinued operations. The sale with an equity value of €1.6 billion was subsequently finalized on 01 April 2021.

Balance sheet FY 2022

Assets in € millionYear-end 2022Year-end             2021
Intangible Assets5,1475,309
Property, Plant & Equipment3,5763,964
Deferred Tax Assets95203
Employee benefits1975
Share in Associates & Joint Ventures6164
Financial derivatives8248
Other Financial Assets295227
Non-Current Assets9,2759,890
Inventories2,2392,297
Trade Receivables1,5081,604
Income tax receivables3661
Other Current Receivables7832
Financial Derivatives4230
Current Investments125489
Cash & Cash Equivalents2,7551,561
Sub-total6,8836,074
Assets Held for Sale1,24556
Current Assets8,1286,130
Total Assets17,40316,020
Shareholders' Equity10,7439,318
Non-controlling interest10279
Equity10,8459,397
Deferred Tax Liabilities476490
Employee Benefits Liabilities241323
Provisions7496
Borrowings2,9782,995
Financial derivatives49
Other Non-current Liabilities205280
Non-current liabilities3,9784,193
Employee Benefits2221
Provisions5068
Borrowings86103
Financial Derivatives2340
Trade Payables1,4151,571
Income tax payable6477
Other Current Liabilities490540
Sub-total2,1502,420
Liabilities associated with the assets held for sale43010
Current Liabilities2,5802,430
Total Equity and Liabilities17,40316,020
Net debt871,019
Equity/Total Assets 62%59%

Income statement FY 2022

Continuing operations in € millionFY 2022FY 2021
Sales8,3907,269
Gross margin2,6902,612
Operating profit (EBIT)682711
Financial income and expense-88-100
Profit before income tax expense594611
Income tax expense-124-123
Share of the profit of associates/
joint control entities
5342
Net profit from continuing operations475830
Net profit from discontinuing operations1,240850
Net profit for the period1,7151,680
Of which:  
Attributable to non-controlling interests154
Dividend on cumulative preference shares64
Available to holders of ordinary shares1,6941,670

Cash flow statement FY 2022

in € millionFY 2022FY 2021
 Cash, Cash Equivalents and Current Investments (at beginning of period) 1,561871
 Operating Activities   
 EBITDA 2,6462,370
 Change in Working  Capital -497-144
 Income Tax  -131-133
Proceeds divestments-1,031-640
 Other -22-26
 Cash provided by Operating Activities (Operating cash flow)  9651,427
 of which provided by continuing operations  7751,040
 Investing Activities   
 Capital Expenditures  -644-570
 Payments regarding drawing rights -7-7
 Acquisitions -74 -704
 Disposal of Subsidiaries, Businesses & Associates 1,3661,791
 Disposal of Other Non-current Assets 47150
 Change in Fixed-term Deposits 363-445
 Interest Received 65
 Dividend and capital (re)payments  -29-31
 Other -15219
 Cash used in Investing Activities 876208
 Financing Activities   
Dividend -345-266
 Interest Paid  -52-65
 Repurchase of shares -210-165
 Proceeds from re-issued treasury shares 2534
 Proceeds from / repayments of corporate bonds  -500
 Payment of lease liabilities -57-54
 Other Cash from/ used in Financing Activities  -632
 Cash from / used in Financing Activities-645-984
 Exchange Differences -239
 Cash and Cash Equivalents (end of period) 2,7551,561

Read more